Indication
Mucocutaneous herpes simplex
Mucocutaneous herpes simplex refers to a localized viral infection of the skin and mucous membranes caused by herpes simplex virus type 1 (HSV-1) or type 2 (HSV-2). Read more about Mucocutaneous herpes simplex
69 drugs 64 manufacturers
Drugs that treat it
Common Mucocutaneous herpes simplex therapies.
ACYCLOVIR
ACYCLOVIR
ACYCLOVIR
ACYCLOVIR SODIUM
ZOVIRAX (acyclovir)
ACYCLOVIR
ACYCLOVIR
ACYCLOVIR
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonMucocutaneous herpes simplex refers to a localized viral infection of the skin and mucous membranes caused by herpes simplex virus type 1 (HSV-1) or type 2 (HSV-2).
It primarily affects the integumentary and mucosal epithelial surfaces—most frequently involving the oral, perioral, or anogenital regions—in both immunocompetent and immunocompromised hosts.
Pathophysiologically, the virus replicates within epithelial cells following primary exposure or reactivation from latent sensory nerve ganglia, clinically producing clusters of painful, fluid-filled vesicles on an erythematous base that subsequently rupture, ulcerate, and crust.
While typically episodic and self-limited in healthy individuals, the condition can present with prolonged, extensive, or necrotic ulcerations in patients with impaired cell-mediated immunity.
- fda.gov
Mucocutaneous herpes simplex refers to a localized viral infection of the skin and mucous membranes caused by herpes simplex virus type 1 (HSV-1) or type 2 (HSV-2) It primarily affects the integumentary and mucosal epithelial surfaces—most frequently involving the oral, perioral, or anogenital regions—in both immunocompetent and immunocompromised hosts Pathophysiologically, the virus replicates within epithelial cells following primary exposure or reactivation from latent sensory nerve ganglia, ...
- merckmanuals.com
Mucocutaneous herpes simplex refers to a localized viral infection of the skin and mucous membranes caused by herpes simplex virus type 1 (HSV-1) or type 2 (HSV-2) While typically episodic and self-limited in healthy individuals, the condition can present with prolonged, extensive, or necrotic ulcerations in patients with impaired cell-mediated immunity
- drugs.com
It primarily affects the integumentary and mucosal epithelial surfaces—most frequently involving the oral, perioral, or anogenital regions—in both immunocompetent and immunocompromised hosts
- clevelandclinic.org
Pathophysiologically, the virus replicates within epithelial cells following primary exposure or reactivation from latent sensory nerve ganglia, clinically producing clusters of painful, fluid-filled vesicles on an erythematous base that subsequently rupture, ulcerate, and crust
- nih.gov
While typically episodic and self-limited in healthy individuals, the condition can present with prolonged, extensive, or necrotic ulcerations in patients with impaired cell-mediated immunity
Personalize your experience
Follow Mucocutaneous herpes simplex and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.